Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancer

Purpose: Clinical success of cancer therapy is severely limited by drug resistance, attributed in large part to the loss of function of tumor suppressor genes (TSGs). Developing effective strategies to treat those tumors is challenging, but urgently needed in clinic. Experimental Design: MYOCD is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qian, Chen, Wensheng, Fan, Zhenzhen, Chen, Zhipeng, Liang, Jinxia, Zeng, Guandi, Liu, Lu, Liu, Wanting, Yang, Tong, Cao, Xin, Yu, Biao, Xu, Meng, Chen, Ye-Guang, Chen, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120205/
https://www.ncbi.nlm.nih.gov/pubmed/33995678
http://dx.doi.org/10.7150/thno.59816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120205/
https://www.ncbi.nlm.nih.gov/pubmed/33995678
http://dx.doi.org/10.7150/thno.59816

Ejemplares similares